Literature DB >> 23457195

Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene.

Silva Saarinen1, Eevi Kaasinen, Marja-Liisa Karjalainen-Lindsberg, Kari Vesanen, Mervi Aavikko, Riku Katainen, Minna Taskinen, Soili Kytölä, Sirpa Leppä, Marja Hietala, Pia Vahteristo, Lauri A Aaltonen.   

Abstract

Primary mediastinal large B-cell lymphoma (PMBCL) is a subtype of diffuse large B-cell lymphoma (DLBCL) accounting for 2% to 4% of all non-Hodgkin lymphomas. We report a family of 3 siblings with PMBCL and their cousin with extranodal DLBCL. The histopathological characteristics of lymphomas of all 4 patients are similar, implying post-germinal center differentiation and growth deregulation by other mechanisms than BCL2-mediated inhibition of apoptosis and suggesting a shared biological background. We aimed to identify the genetic defect underlying lymphoma susceptibility in this family using exome sequencing and linkage analysis. The only variant segregating in all 4 patients and not reported in genetic databases was 5533C>A (His1845Asn) in the MLL gene. To our knowledge, this is the first time when familial clustering of PMBCL is reported. Although we propose MLL as a candidate predisposition gene for this condition, this finding needs to be validated in additional cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23457195     DOI: 10.1182/blood-2012-06-437210

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling.

Authors:  Ji Yuan; George Wright; Andreas Rosenwald; Christian Steidl; Randy D Gascoyne; Joseph M Connors; Anja Mottok; Dennis D Weisenburger; Timothy C Greiner; Kai Fu; Lynette Smith; Lisa M Rimsza; Elaine S Jaffe; Elias Campo; Antonio Martinez; Jan Delabie; Rita M Braziel; James R Cook; German Ott; Julie M Vose; Louis M Staudt; Wing C Chan
Journal:  Am J Surg Pathol       Date:  2015-10       Impact factor: 6.394

Review 2.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

3.  Primary mediastinal large B-cell lymphoma.

Authors:  Anna Dabrowska-Iwanicka; Jan A Walewski
Journal:  Curr Hematol Malig Rep       Date:  2014-09       Impact factor: 3.952

Review 4.  Germline mutations predisposing to diffuse large B-cell lymphoma.

Authors:  O C Leeksma; N F de Miranda; H Veelken
Journal:  Blood Cancer J       Date:  2017-02-17       Impact factor: 11.037

5.  Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans.

Authors:  Eevi Kaasinen; Outi Kuismin; Kristiina Rajamäki; Heikki Ristolainen; Mervi Aavikko; Johanna Kondelin; Silva Saarinen; Davide G Berta; Riku Katainen; Elina A M Hirvonen; Auli Karhu; Aurora Taira; Tomas Tanskanen; Amjad Alkodsi; Minna Taipale; Ekaterina Morgunova; Kaarle Franssila; Rainer Lehtonen; Markus Mäkinen; Kristiina Aittomäki; Aarno Palotie; Mitja I Kurki; Olli Pietiläinen; Morgane Hilpert; Elmo Saarentaus; Jaakko Niinimäki; Juhani Junttila; Kari Kaikkonen; Pia Vahteristo; Radek C Skoda; Mikko R J Seppänen; Kari K Eklund; Jussi Taipale; Outi Kilpivaara; Lauri A Aaltonen
Journal:  Nat Commun       Date:  2019-03-19       Impact factor: 14.919

6.  A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia.

Authors:  Haixia Zhang; Bingwu Xiang; Hui Chen; Xiang Chen; Tao Cai
Journal:  BMC Med Genet       Date:  2019-03-06       Impact factor: 2.103

7.  TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells.

Authors:  Regula Burkhard; Irene Keller; Miroslav Arambasic; Darius Juskevicius; Alexandar Tzankov; Pontus Lundberg; Rémy Bruggmann; Stephan Dirnhofer; Ramin Radpour; Urban Novak
Journal:  Haematologica       Date:  2018-10-31       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.